LBEL Effet Parfait Mineral Natural Skin Effect Mouse Foundation

Manufacturer: Ventura International, Limited | BelStar, S.A.
Effective date: 2010-11-10
Label type: HUMAN OTC DRUG LABEL
Version: 1
Source: legacy-cache
Hydrated at: 2026-08-02 01:52:07

Label at a glance#

ProductLBEL Effet Parfait Mineral Natural Skin Effect Mouse Foundation

Active ingredientOCTINOXATE, TITANIUM DIOXIDE, ZINC OXIDE

Label structure9 sections

Indications and uses

Helps prevent sunburn Higher SPF gives more sunburn protection Provides moderate protection against sunburn

Dosage and administration

Apply generously and evently before sun exposure and as needed

Storage and handling

Sun alert: Limiting sun exposure, waring protective clothing, and using sunscreen may reduce the risk of skin aging, skin cancer, and other harmful effects of the sun.

Label contents#

Full prescribing information#

SPL UNCLASSIFIED SECTION

Drug Facts

OTC - ACTIVE INGREDIENT SECTION

OTC - PURPOSE SECTION

Active Ingredient	Purpose
Octinoxate 6.5%,	Sunscreen
Titanium Dioxide 2.4%	Sunscreen
Zinc Oxide 1.6%	Sunscreen

Uses

INDICATIONS & USAGE SECTION

Helps prevent sunburn
Higher SPF gives more sunburn protection
Provides moderate protection against sunburn

Warnings

WARNINGS SECTION

For external use only

OTC - WHEN USING SECTION

When using this product

Keep out of eyes. Rinse with water to remove.

OTC - STOP USE SECTION

Stop use and ask a doctor if

Rash or irritation develops and lasts

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away.

Directions

DOSAGE & ADMINISTRATION SECTION

Apply generously and evently before sun exposure and as needed

Other information

STORAGE AND HANDLING SECTION

Sun alert: Limiting sun exposure, waring protective clothing, and using sunscreen may reduce the risk of skin aging, skin cancer, and other harmful effects of the sun.

Inactive ingredients

INACTIVE INGREDIENT SECTION

Cyclopentasiloxane, Mica, Dimethicone Crosspolymer, Dimethicone/Vinyl Dimethicone Crosspolymer, Trimethylsiloxysilicate, Cyclohexasiloxane , Bis-hydroxyethoxypropyl Dimethicone, Octyldodecanol, Phenoxyethanol, Boron nitride, Disteardimonium Hectorite, Alumina, Cetyl peg/ppg-10/1 Dimethicone, Polyglyceryl-4 isostearate, Cera Microcristallina (Microcrystalline Wax), Silica, Hexyl Laurate, Dimethiconol, Caprylyl glycol, Tocopheryl Acetate, Chlorphenesin, Lauroyl Lysine, Petrolatum, Propylene Carbonate, Methicone, Phospholipids,Rhodiola Rosea Root Extract, Cholesterol, BHA, BHT, Carnosine, Triethoxycaprylylsilane, Candelilla Cera (Euphorbia Cerifera (candelilla) wax), Cera alba (Beeswax), Cetearyl Alcohol, Cetearyl Glucoside, Copernicia Cerifera Cera (Copernicia Cerifera (carnauba) wax), Polyglyceryl-2 Dipolyhydroxystearate, Glycosphingolipids, Alanyl Glutamine. May Contain: CI 77891(Titanium Dioxide) , CI 77491, CI 77492, CI 77499 (Iron Oxides).

SPL UNCLASSIFIED SECTION

USA: Dist. by Ventura International Ltd. San Francisco, CA 94111. Made in Colombia. PUERTO RICO: Dist. by Ventura Corporation, Ltd., San Juan, Puerto Rico 00926. Made in Colombia.

PRINCIPAL DISPLAY PANEL - 30 g Carton

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

EFFET PARFAIT
MINÉRAL

natural skin effect
mousse foundation
SPF 16

30 g e (1 oz.)

L'BEL

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDC	Effective	Action	Document	Indexing SPL	Related label
14783-770-04	2025-03-11	C162847	48780-1	960f7f55-ccf2-8e05-e053-dbdaa90a074a	EFFET PARFAIT MINÉRAL natural skin effect mousse foundation SPF 16
14783-770-31	2025-03-11	C162847	48780-1	960f7f55-ccf2-8e05-e053-dbdaa90a074a	EFFET PARFAIT MINÉRAL natural skin effect mousse foundation SPF 16
14783-770-04	2019-10-29	C162847	48780-1	960f7f55-ccf2-8e05-e053-dbdaa90a074a	EFFET PARFAIT MINÉRAL natural skin effect mousse foundation SPF 16
14783-770-31	2019-10-29	C162847	48780-1	960f7f55-ccf2-8e05-e053-dbdaa90a074a	EFFET PARFAIT MINÉRAL natural skin effect mousse foundation SPF 16

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	SPL version
OCTINOXATE	ACTIVE INGREDIENT	4Y5P7MUD51	1
TITANIUM DIOXIDE	ACTIVE INGREDIENT	15FIX9V2JP	1
ZINC OXIDE	ACTIVE INGREDIENT	SOI2LOH54Z	1
OCTINOXATE	ACTIVE MOIETY	4Y5P7MUD51	1
TITANIUM DIOXIDE	ACTIVE MOIETY	15FIX9V2JP	1
ZINC OXIDE	ACTIVE MOIETY	SOI2LOH54Z	1
ALANYL-GLUTAMINE	INACTIVE INGREDIENT	U5JDO2770Z	1
ALUMINUM OXIDE	INACTIVE INGREDIENT	LMI26O6933	1
BUTYLATED HYDROXYANISOLE	INACTIVE INGREDIENT	REK4960K2U	1
BUTYLATED HYDROXYTOLUENE	INACTIVE INGREDIENT	1P9D0Z171K	1
CANDELILLA WAX	INACTIVE INGREDIENT	WL0328HX19	1
CAPRYLYL GLYCOL	INACTIVE INGREDIENT	00YIU5438U	1
CARNAUBA WAX	INACTIVE INGREDIENT	R12CBM0EIZ	1
CARNOSINE	INACTIVE INGREDIENT	8HO6PVN24W	1
CETEARYL GLUCOSIDE	INACTIVE INGREDIENT	09FUA47KNA	1
CETOSTEARYL ALCOHOL	INACTIVE INGREDIENT	2DMT128M1S	1
CHLORPHENESIN	INACTIVE INGREDIENT	I670DAL4SZ	1
CHOLESTEROL	INACTIVE INGREDIENT	97C5T2UQ7J	1
CYCLOMETHICONE 5	INACTIVE INGREDIENT	0THT5PCI0R	1
CYCLOMETHICONE 6	INACTIVE INGREDIENT	XHK3U310BA	1
FERRIC OXIDE RED	INACTIVE INGREDIENT	1K09F3G675	1
FERRIC OXIDE YELLOW	INACTIVE INGREDIENT	EX438O2MRT	1
FERROSOFERRIC OXIDE	INACTIVE INGREDIENT	XM0M87F357	1
HEXYL LAURATE	INACTIVE INGREDIENT	4CG9F9W01Q	1
LAUROYL LYSINE	INACTIVE INGREDIENT	113171Q70B	1
MICA	INACTIVE INGREDIENT	V8A1AW0880	1
MICROCRYSTALLINE WAX	INACTIVE INGREDIENT	XOF597Q3KY	1
OCTYLDODECANOL	INACTIVE INGREDIENT	461N1O614Y	1
PETROLATUM	INACTIVE INGREDIENT	4T6H12BN9U	1
PHENOXYETHANOL	INACTIVE INGREDIENT	HIE492ZZ3T	1
POLYGLYCERYL-4 ISOSTEARATE	INACTIVE INGREDIENT	820DPX33S7	1
PROPYLENE CARBONATE	INACTIVE INGREDIENT	8D08K3S51E	1
SILICON DIOXIDE	INACTIVE INGREDIENT	ETJ7Z6XBU4	1
YELLOW WAX	INACTIVE INGREDIENT	2ZA36H0S2V	1

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 33 matching rows.

LBEL Effet Parfait Mineral Natural Skin Effect Mouse Foundation
OCTINOXATE, TITANIUM DIOXIDE, and ZINC OXIDE
OCTINOXATE
TITANIUM DIOXIDE
ZINC OXIDE
CYCLOMETHICONE 5
MICA
CYCLOMETHICONE 6
OCTYLDODECANOL
PHENOXYETHANOL
ALUMINUM OXIDE
POLYGLYCERYL-4 ISOSTEARATE
MICROCRYSTALLINE WAX
SILICON DIOXIDE
HEXYL LAURATE
CAPRYLYL GLYCOL
CHLORPHENESIN
LAUROYL LYSINE
PETROLATUM
PROPYLENE CARBONATE
CHOLESTEROL
BUTYLATED HYDROXYANISOLE
BUTYLATED HYDROXYTOLUENE
CARNOSINE
CANDELILLA WAX
YELLOW WAX
CETOSTEARYL ALCOHOL
CETEARYL GLUCOSIDE
CARNAUBA WAX
ALANYL-GLUTAMINE
FERRIC OXIDE RED
FERRIC OXIDE YELLOW
FERROSOFERRIC OXIDE

NDC Codes#

Product NDC, Package NDC table
Product NDC	Package NDC
14783-770	14783-770-30, 14783-770-31, 14783-770-03, 14783-770-04

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 31 matching rows.

Name, UNII, Kind table
Name	UNII	Kind
OCTINOXATE	4Y5P7MUD51	ACTIB
TITANIUM DIOXIDE	15FIX9V2JP	ACTIB
ZINC OXIDE	SOI2LOH54Z	ACTIB
CYCLOMETHICONE 5	0THT5PCI0R	IACT
MICA	V8A1AW0880	IACT
CYCLOMETHICONE 6	XHK3U310BA	IACT
OCTYLDODECANOL	461N1O614Y	IACT
PHENOXYETHANOL	HIE492ZZ3T	IACT
ALUMINUM OXIDE	LMI26O6933	IACT
POLYGLYCERYL-4 ISOSTEARATE	820DPX33S7	IACT
MICROCRYSTALLINE WAX	XOF597Q3KY	IACT
SILICON DIOXIDE	ETJ7Z6XBU4	IACT
HEXYL LAURATE	4CG9F9W01Q	IACT
CAPRYLYL GLYCOL	00YIU5438U	IACT
CHLORPHENESIN	I670DAL4SZ	IACT
LAUROYL LYSINE	113171Q70B	IACT
PETROLATUM	4T6H12BN9U	IACT
PROPYLENE CARBONATE	8D08K3S51E	IACT
CHOLESTEROL	97C5T2UQ7J	IACT
BUTYLATED HYDROXYANISOLE	REK4960K2U	IACT
BUTYLATED HYDROXYTOLUENE	1P9D0Z171K	IACT
CARNOSINE	8HO6PVN24W	IACT
CANDELILLA WAX	WL0328HX19	IACT
YELLOW WAX	2ZA36H0S2V	IACT
CETOSTEARYL ALCOHOL	2DMT128M1S	IACT
CETEARYL GLUCOSIDE	09FUA47KNA	IACT
CARNAUBA WAX	R12CBM0EIZ	IACT
ALANYL-GLUTAMINE	U5JDO2770Z	IACT
FERRIC OXIDE RED	1K09F3G675	IACT
FERRIC OXIDE YELLOW	EX438O2MRT	IACT
FERROSOFERRIC OXIDE	XM0M87F357	IACT

Source Document#

Source XML

Inactive ingredient matches#

Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.

Inactive ingredient links page 1 of 5 · 242 matching rows.

DailyMed ingredient, IID ingredient, UNII table
DailyMed ingredient	IID ingredient	UNII	Dosage form / route	Potency	Maximum daily exposure	Match
FERROSOFERRIC OXIDE	FERROSOFERRIC OXIDE	XM0M87F357	CAPSULE, DELAYED RELEASE / ORAL		6 mg	Exact identifier — unii candidate 10 equally ranked IID candidates
SILICON DIOXIDE	SILICON DIOXIDE	ETJ7Z6XBU4	TABLET / ORAL		750 mg	Exact identifier — unii candidate 49 equally ranked IID candidates
FERRIC OXIDE YELLOW	FERRIC OXIDE YELLOW	EX438O2MRT	TABLET / SUBLINGUAL	1 mg		Exact identifier — unii candidate 20 equally ranked IID candidates
BUTYLATED HYDROXYTOLUENE	BUTYLATED HYDROXYTOLUENE	1P9D0Z171K	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / INTRAVENOUS	0.02 mg		Exact identifier — unii candidate 32 equally ranked IID candidates
FERRIC OXIDE YELLOW	FERRIC OXIDE YELLOW	EX438O2MRT	TABLET / ORAL		24 mg	Exact identifier — unii candidate 20 equally ranked IID candidates
CHOLESTEROL	CHOLESTEROL	97C5T2UQ7J	CREAM / TOPICAL	1 %w/w		Exact identifier — unii candidate 10 equally ranked IID candidates
FERRIC OXIDE RED	FERRIC OXIDE RED	1K09F3G675	CAPSULE, EXTENDED RELEASE / ORAL		5 mg	Exact identifier — unii candidate 21 equally ranked IID candidates
FERROSOFERRIC OXIDE	FERROSOFERRIC OXIDE	XM0M87F357	TABLET, FILM COATED / ORAL	0.2 mg		Exact identifier — unii candidate 10 equally ranked IID candidates
OCTYLDODECANOL	OCTYLDODECANOL	461N1O614Y	LOTION / TOPICAL		714 mg	Exact identifier — unii candidate 9 equally ranked IID candidates
BUTYLATED HYDROXYTOLUENE	BUTYLATED HYDROXYTOLUENE	1P9D0Z171K	SHAMPOO / TOPICAL	0.1 %w/w		Exact identifier — unii candidate 32 equally ranked IID candidates
SILICON DIOXIDE	SILICON DIOXIDE	ETJ7Z6XBU4	GRANULE, FOR SUSPENSION / ORAL		200 mg	Exact identifier — unii candidate 49 equally ranked IID candidates
SILICON DIOXIDE	SILICON DIOXIDE	ETJ7Z6XBU4	TABLET, FILM COATED, EXTENDED RELEASE / ORAL		336 mg	Exact identifier — unii candidate 49 equally ranked IID candidates
SILICON DIOXIDE	SILICON DIOXIDE	ETJ7Z6XBU4	SUSPENSION, EXTENDED RELEASE / ORAL		70 mg	Exact identifier — unii candidate 49 equally ranked IID candidates
BUTYLATED HYDROXYANISOLE	BUTYLATED HYDROXYANISOLE	REK4960K2U	CAPSULE / ORAL		4 mg	Exact identifier — unii candidate 24 equally ranked IID candidates
FERRIC OXIDE YELLOW	FERRIC OXIDE YELLOW	EX438O2MRT	TABLET, ORALLY DISINTEGRATING / ORAL		2 mg	Exact identifier — unii candidate 20 equally ranked IID candidates
FERRIC OXIDE RED	FERRIC OXIDE RED	1K09F3G675	CAPSULE, DELAYED RELEASE / ORAL		14 mg	Exact identifier — unii candidate 21 equally ranked IID candidates
SILICON DIOXIDE	SILICON DIOXIDE	ETJ7Z6XBU4	TABLET, DELAYED RELEASE PARTICLES / ORAL		170 mg	Exact identifier — unii candidate 49 equally ranked IID candidates
SILICON DIOXIDE	SILICON DIOXIDE	ETJ7Z6XBU4	LOZENGE / ORAL		120 mg	Exact identifier — unii candidate 49 equally ranked IID candidates
PETROLATUM	PETROLATUM	4T6H12BN9U	SPONGE / TOPICAL	NA		Exact identifier — unii candidate 18 equally ranked IID candidates
CETOSTEARYL ALCOHOL	CETOSTEARYL ALCOHOL	2DMT128M1S	SPRAY / TOPICAL	1 %w/w		Exact identifier — unii candidate 9 equally ranked IID candidates
BUTYLATED HYDROXYTOLUENE	BUTYLATED HYDROXYTOLUENE	1P9D0Z171K	SPRAY / TOPICAL		3 mg	Exact identifier — unii candidate 32 equally ranked IID candidates
SILICON DIOXIDE	SILICON DIOXIDE	ETJ7Z6XBU4	CAPSULE / ORAL		300 mg	Exact identifier — unii candidate 49 equally ranked IID candidates
CETOSTEARYL ALCOHOL	CETOSTEARYL ALCOHOL	2DMT128M1S	CREAM / TOPICAL		1428 mg	Exact identifier — unii candidate 9 equally ranked IID candidates
BUTYLATED HYDROXYTOLUENE	BUTYLATED HYDROXYTOLUENE	1P9D0Z171K	CREAM, AUGMENTED / TOPICAL	0.2 %w/w		Exact identifier — unii candidate 32 equally ranked IID candidates
BUTYLATED HYDROXYANISOLE	BUTYLATED HYDROXYANISOLE	REK4960K2U	CONCENTRATE / ORAL	0.08 mg/1ml		Exact identifier — unii candidate 24 equally ranked IID candidates
CHOLESTEROL	CHOLESTEROL	97C5T2UQ7J	INJECTABLE, LIPOSOMAL / INFILTRATION	0.47 %w/v		Exact identifier — unii candidate 10 equally ranked IID candidates
MICROCRYSTALLINE WAX	MICROCRYSTALLINE WAX	XOF597Q3KY	OINTMENT / TOPICAL		3575 mg	Exact identifier — unii candidate 4 equally ranked IID candidates
BUTYLATED HYDROXYTOLUENE	BUTYLATED HYDROXYTOLUENE	1P9D0Z171K	INJECTION, SOLUTION / INTRAVENOUS	NA		Exact identifier — unii candidate 32 equally ranked IID candidates
SILICON DIOXIDE	SILICON DIOXIDE	ETJ7Z6XBU4	TABLET, COATED / ORAL		176 mg	Exact identifier — unii candidate 49 equally ranked IID candidates
CANDELILLA WAX	CANDELILLA WAX	WL0328HX19	TABLET, DELAYED RELEASE / ORAL		1 mg	Exact identifier — unii candidate 4 equally ranked IID candidates
FERROSOFERRIC OXIDE	FERROSOFERRIC OXIDE	XM0M87F357	POWDER, FOR SUSPENSION / ORAL	NA		Exact identifier — unii candidate 10 equally ranked IID candidates
BUTYLATED HYDROXYANISOLE	BUTYLATED HYDROXYANISOLE	REK4960K2U	INJECTION, POWDER, FOR SOLUTION / INTRAVENOUS	NA		Exact identifier — unii candidate 24 equally ranked IID candidates
SILICON DIOXIDE	SILICON DIOXIDE	ETJ7Z6XBU4	CREAM / VAGINAL		51 mg	Exact identifier — unii candidate 49 equally ranked IID candidates
CARNAUBA WAX	CARNAUBA WAX	R12CBM0EIZ	GUM, CHEWING / BUCCAL		10 mg	Exact identifier — unii candidate 11 equally ranked IID candidates
CHOLESTEROL	CHOLESTEROL	97C5T2UQ7J	INJECTION, POWDER, FOR SUSPENSION / INTRAVENOUS	52 mg		Exact identifier — unii candidate 10 equally ranked IID candidates
FERRIC OXIDE RED	FERRIC OXIDE RED	1K09F3G675	CREAM / TOPICAL	NA		Exact identifier — unii candidate 21 equally ranked IID candidates
YELLOW WAX	YELLOW WAX	2ZA36H0S2V	CAPSULE / ORAL		44 mg	Exact identifier — unii candidate 9 equally ranked IID candidates
FERRIC OXIDE YELLOW	FERRIC OXIDE YELLOW	EX438O2MRT	TABLET / BUCCAL		1 mg	Exact identifier — unii candidate 20 equally ranked IID candidates
SILICON DIOXIDE	SILICON DIOXIDE	ETJ7Z6XBU4	TABLET / SUBLINGUAL		10 mg	Exact identifier — unii candidate 49 equally ranked IID candidates
SILICON DIOXIDE	SILICON DIOXIDE	ETJ7Z6XBU4	GRANULE, FOR SUSPENSION, EXTENDED RELEASE / ORAL	NA		Exact identifier — unii candidate 49 equally ranked IID candidates
FERRIC OXIDE YELLOW	FERRIC OXIDE YELLOW	EX438O2MRT	TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE / ORAL		2 mg	Exact identifier — unii candidate 20 equally ranked IID candidates
BUTYLATED HYDROXYTOLUENE	BUTYLATED HYDROXYTOLUENE	1P9D0Z171K	SOLUTION / ORAL		14 mg	Exact identifier — unii candidate 32 equally ranked IID candidates
FERRIC OXIDE RED	FERRIC OXIDE RED	1K09F3G675	CAPSULE, COATED PELLETS / ORAL	2 mg		Exact identifier — unii candidate 21 equally ranked IID candidates
BUTYLATED HYDROXYANISOLE	BUTYLATED HYDROXYANISOLE	REK4960K2U	TABLET, ORALLY DISINTEGRATING / ORAL		2 mg	Exact identifier — unii candidate 24 equally ranked IID candidates
BUTYLATED HYDROXYANISOLE	BUTYLATED HYDROXYANISOLE	REK4960K2U	GEL / TOPICAL		7 mg	Exact identifier — unii candidate 24 equally ranked IID candidates
PETROLATUM	PETROLATUM	4T6H12BN9U	OINTMENT / AURICULAR (OTIC)	NA		Exact identifier — unii candidate 18 equally ranked IID candidates
PETROLATUM	PETROLATUM	4T6H12BN9U	CAPSULE, EXTENDED RELEASE / ORAL	0.07 mg		Exact identifier — unii candidate 18 equally ranked IID candidates
SILICON DIOXIDE	SILICON DIOXIDE	ETJ7Z6XBU4	TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE / ORAL		69 mg	Exact identifier — unii candidate 49 equally ranked IID candidates
FERROSOFERRIC OXIDE	FERROSOFERRIC OXIDE	XM0M87F357	CAPSULE, EXTENDED RELEASE / ORAL	1.49 mg		Exact identifier — unii candidate 10 equally ranked IID candidates
BUTYLATED HYDROXYTOLUENE	BUTYLATED HYDROXYTOLUENE	1P9D0Z171K	SUPPOSITORY / VAGINAL	NA		Exact identifier — unii candidate 32 equally ranked IID candidates
SILICON DIOXIDE	SILICON DIOXIDE	ETJ7Z6XBU4	GEL / DENTAL	19 %w/w		Exact identifier — unii candidate 49 equally ranked IID candidates
MICROCRYSTALLINE WAX	MICROCRYSTALLINE WAX	XOF597Q3KY	CREAM / VAGINAL		23 mg	Exact identifier — unii candidate 4 equally ranked IID candidates
FERROSOFERRIC OXIDE	FERROSOFERRIC OXIDE	XM0M87F357	CAPSULE / ORAL		11 mg	Exact identifier — unii candidate 10 equally ranked IID candidates
BUTYLATED HYDROXYANISOLE	BUTYLATED HYDROXYANISOLE	REK4960K2U	CAPSULE, LIQUID FILLED / ORAL		4 mg	Exact identifier — unii candidate 24 equally ranked IID candidates
BUTYLATED HYDROXYANISOLE	BUTYLATED HYDROXYANISOLE	REK4960K2U	GRANULE, FOR SUSPENSION / ORAL	NA		Exact identifier — unii candidate 24 equally ranked IID candidates
FERRIC OXIDE RED	FERRIC OXIDE RED	1K09F3G675	TABLET, FILM COATED, EXTENDED RELEASE / ORAL	3.6 mg		Exact identifier — unii candidate 21 equally ranked IID candidates
BUTYLATED HYDROXYTOLUENE	BUTYLATED HYDROXYTOLUENE	1P9D0Z171K	TABLET, ORALLY DISINTEGRATING / ORAL		1 mg	Exact identifier — unii candidate 32 equally ranked IID candidates
PETROLATUM	PETROLATUM	4T6H12BN9U	SUPPOSITORY / VAGINAL	27 mg		Exact identifier — unii candidate 18 equally ranked IID candidates
FERRIC OXIDE RED	FERRIC OXIDE RED	1K09F3G675	POWDER, FOR SUSPENSION / ORAL		1 mg	Exact identifier — unii candidate 21 equally ranked IID candidates
BUTYLATED HYDROXYTOLUENE	BUTYLATED HYDROXYTOLUENE	1P9D0Z171K	INJECTION / INTRAVENOUS	NA		Exact identifier — unii candidate 32 equally ranked IID candidates

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
301759d2-e7fb-c6df-e063-6394a90ab9c4			d495d956-fe74-4727-ba8d-d960308b3518	2025-03-11	Warnings	Exact identifier spl set id: d495d956-fe74-4727-ba8d-d960308b3518

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.